Synopsys, Inc. $SNPS Shares Purchased by Calamos Advisors LLC

Calamos Advisors LLC raised its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 180.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,854 shares of the semiconductor company’s stock after acquiring an additional 103,560 shares during the period. Calamos Advisors LLC owned approximately 0.08% of Synopsys worth $69,962,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Alta Advisers Ltd grew its position in Synopsys by 91.9% in the 3rd quarter. Alta Advisers Ltd now owns 1,376 shares of the semiconductor company’s stock worth $598,000 after purchasing an additional 659 shares during the last quarter. Legacies Wealth LLC acquired a new position in shares of Synopsys during the third quarter valued at about $34,000. Kestra Advisory Services LLC lifted its stake in shares of Synopsys by 35.8% in the third quarter. Kestra Advisory Services LLC now owns 7,295 shares of the semiconductor company’s stock valued at $3,173,000 after buying an additional 1,923 shares during the period. Capital Investment Services of America Inc. lifted its stake in shares of Synopsys by 6.0% in the third quarter. Capital Investment Services of America Inc. now owns 33,810 shares of the semiconductor company’s stock valued at $14,705,000 after buying an additional 1,903 shares during the period. Finally, Chicago Partners Investment Group LLC grew its position in Synopsys by 18.1% during the third quarter. Chicago Partners Investment Group LLC now owns 4,564 shares of the semiconductor company’s stock worth $1,963,000 after buying an additional 699 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Robert W. Baird upgraded Synopsys from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. Benchmark reiterated a “buy” rating and issued a $570.00 price objective on shares of Synopsys in a research report on Thursday, August 27th. Mizuho decreased their price objective on Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a report on Thursday, August 27th. Weiss Ratings cut Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. Finally, Roth Capital upgraded shares of Synopsys to a “buy” rating in a research note on Friday, September 25th. One analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $575.00.

Insider Activity at Synopsys

In related news, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the completion of the transaction, the insider owned 16,534 shares in the company, valued at $8,308,665.68. The trade was a 6.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the completion of the transaction, the chief executive officer owned 76,865 shares in the company, valued at $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 117,163 shares of company stock valued at $51,366,457 over the last three months. 0.56% of the stock is owned by company insiders.

Synopsys Price Performance

NASDAQ:SNPS traded up $10.15 on Friday, reaching $450.46. The stock had a trading volume of 2,317,784 shares, compared to its average volume of 2,279,157. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $86.33 billion, a P/E ratio of 79.59, a price-to-earnings-growth ratio of 1.48 and a beta of 1.18. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48. The stock has a fifty day moving average price of $441.61 and a 200-day moving average price of $442.27.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the company posted $3.39 earnings per share. The firm’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts forecast that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its Board of Directors has initiated a stock repurchase plan on Monday, October 5th that permits the company to buy back $1 billion in outstanding shares. This buyback authorization permits the semiconductor company to purchase up to 1.1% of its shares through open market purchases. Share buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

Synopsys Company Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.